Index RUT P/E - EPS (ttm) -4.41 Insider Own 7.16% Shs Outstand 50.63M Perf Week 7.73%
Market Cap 236.44M Forward P/E - EPS next Y -0.68 Insider Trans 22.75% Shs Float 47.72M Perf Month -6.88%
Income -217.57M PEG - EPS next Q -0.75 Inst Own 93.15% Short Float 13.58% Perf Quarter -10.51%
Sales 100.39M P/S 2.36 EPS this Y 56.23% Inst Trans -1.52% Short Ratio 4.61 Perf Half Y 103.54%
Book/sh 5.04 P/B 0.91 EPS next Y 64.93% ROA -35.61% Short Interest 6.48M Perf Year -55.34%
Cash/sh 4.22 P/C 1.09 EPS next 5Y - ROE -76.91% 52W Range 1.53 - 12.69 Perf YTD 7.73%
Dividend Est. - P/FCF - EPS past 5Y - ROI -43.57% 52W High -63.75% Beta 1.87
Dividend TTM - Quick Ratio 3.98 Sales past 5Y 73.45% Gross Margin 72.90% 52W Low 199.67% ATR (14) 0.44
Dividend Ex-Date - Current Ratio 3.98 EPS Y/Y TTM 41.77% Oper. Margin -215.87% RSI (14) 46.54 Volatility 10.69% 9.07%
Employees 274 Debt/Eq 1.01 Sales Y/Y TTM 9.72% Profit Margin -216.73% Recom 2.14 Target Price 11.80
Option/Short Yes / Yes LT Debt/Eq 0.96 EPS Q/Q -84.82% Payout - Rel Volume 0.54 Prev Close 4.56
Sales Surprise -27.35% EPS Surprise -7.24% Sales Q/Q -80.98% Earnings Mar 05 BMO Avg Volume 1.41M Price 4.60
SMA20 -5.30% SMA50 -7.96% SMA200 1.51% Trades
Volume 761,430 Change 0.88%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-31-24 Upgrade Leerink Partners
Market Perform → Outperform
$5 → $18
Jan-31-24 Downgrade TD Cowen
Outperform → Market Perform
Oct-30-23 Downgrade Leerink Partners
Outperform → Market Perform
$6
Oct-12-23 Initiated Citigroup
Buy
$13
Sep-13-23 Downgrade Goldman
Buy → Neutral
$5
Sep-12-23 Downgrade Guggenheim
Buy → Neutral
Jul-28-23 Downgrade Morgan Stanley
Overweight → Equal-Weight
$25 → $13
Oct-31-22 Initiated Guggenheim
Buy
$30
May-02-22 Initiated Goldman
Buy
$26
Feb-10-22 Initiated SVB Leerink
Outperform
$38
Jan-06-22 Initiated Cowen
Outperform
Nov-09-21 Initiated Canaccord Genuity
Buy
$42
Nov-08-21 Initiated Wedbush
Outperform
Nov-08-21 Initiated Morgan Stanley
Overweight
Show Previous Ratings
Apr-24-24 10:01AM
Apr-17-24 11:02AM
Apr-05-24 09:05AM
Apr-01-24 07:30AM
Mar-20-24 05:04PM
06:27PM
Loading…
Mar-15-24 06:27PM
Mar-07-24 09:10AM
Mar-05-24 07:53AM
07:00AM
Mar-04-24 08:56AM
Mar-01-24 07:00AM
Feb-27-24 08:00AM
Feb-05-24 04:05PM
06:59AM
Feb-01-24 08:27AM
11:11AM
Loading…
Jan-31-24 11:11AM
Jan-30-24 07:01AM
Jan-12-24 12:00PM
Dec-11-23 07:30PM
07:00AM
Dec-06-23 02:00PM
Nov-20-23 12:02PM
06:59AM
Nov-14-23 07:00AM
Nov-10-23 07:00AM
Sep-12-23 07:00AM
06:55AM
Sep-06-23 07:00AM
Aug-24-23 09:00PM
Aug-14-23 07:00AM
07:00AM
Loading…
Aug-08-23 07:00AM
Aug-01-23 04:15PM
Jun-14-23 07:00AM
Jun-07-23 07:00AM
May-19-23 06:00AM
May-17-23 07:17AM
May-11-23 12:37PM
May-03-23 04:05PM
May-02-23 04:37PM
10:00AM
May-01-23 07:00AM
Apr-28-23 08:30AM
Apr-17-23 06:59AM
Mar-16-23 04:05PM
Mar-08-23 08:30AM
Mar-03-23 07:00AM
Mar-01-23 09:00AM
Feb-28-23 09:00PM
04:01PM
Feb-10-23 11:13AM
Feb-01-23 07:30AM
Jan-18-23 11:35AM
Jan-09-23 08:00AM
Jan-06-23 09:11AM
Nov-07-22 04:05PM
Nov-03-22 09:06AM
Oct-27-22 07:00AM
Sep-07-22 07:00AM
Aug-31-22 07:30AM
Aug-12-22 06:23AM
Aug-10-22 06:50AM
06:45AM
Aug-04-22 07:02AM
Aug-03-22 07:30AM
Jul-04-22 03:30PM
Jun-06-22 07:30AM
May-12-22 04:05PM
May-04-22 09:10PM
Apr-08-22 04:15PM
Apr-07-22 07:30AM
Mar-22-22 07:00AM
Mar-16-22 08:41AM
Feb-14-22 07:30AM
07:00AM
Feb-11-22 09:58AM
Feb-03-22 01:38PM
Jan-26-22 08:00AM
Jan-11-22 07:00AM
Jan-06-22 07:00AM
Dec-13-21 06:15PM
Dec-01-21 07:00AM
Nov-15-21 10:43AM
Nov-10-21 04:30PM
2seventy Bio, Inc. operates as cell and gene therapy company. It concentrates on the research, development, and commercialization of transformative treatments for cancer. The company was founded on April 26, 2021 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Casdin Capital, LLC Director Mar 26 '24 Buy 5.10 40,000 203,992 2,000,000 Mar 28 08:29 PM Casdin Capital, LLC Director Mar 25 '24 Buy 5.07 330,000 1,673,991 1,960,000 Mar 25 09:44 PM Casdin Capital, LLC Director Mar 22 '24 Buy 5.12 147,377 754,069 1,630,000 Mar 25 09:44 PM Casdin Capital, LLC Director Mar 21 '24 Buy 4.90 300,000 1,470,990 1,482,623 Mar 25 09:44 PM Leschly Nick President and CEO Jan 05 '24 Sale 3.75 1,554 5,833 1,085,476 Jan 09 04:08 PM Baird William D III Chief Operating Officer Jan 05 '24 Sale 3.75 1,380 5,180 161,335 Jan 09 04:09 PM Gregory Philip D Chief Scientific Officer Jan 05 '24 Sale 3.75 795 2,984 230,842 Jan 09 04:09 PM Leschly Nick President and CEO Jan 03 '24 Sale 3.87 72,312 279,739 1,087,030 Jan 05 04:30 PM Baird William D III Chief Operating Officer Jan 03 '24 Sale 3.87 33,651 130,179 162,715 Jan 05 04:29 PM Gregory Philip D Chief Scientific Officer Jan 03 '24 Sale 3.87 25,613 99,084 231,637 Jan 05 04:30 PM Leschly Nick President and CEO Aug 22 '23 Sale 5.49 9,312 51,090 1,159,342 Aug 24 05:04 PM Baird William D III Chief Financial Officer Aug 22 '23 Sale 5.49 7,031 38,576 196,366 Aug 24 05:04 PM Gregory Philip D Chief Scientific Officer Aug 22 '23 Sale 5.49 6,159 33,791 257,250 Aug 24 05:04 PM Kynam Capital Management, LP 10% Owner Aug 10 '23 Buy 5.92 515,414 3,049,287 5,953,825 Aug 14 08:51 PM Kynam Global Healthcare Master 10% Owner Aug 10 '23 Buy 5.92 515,414 3,049,287 5,953,825 Aug 16 07:11 PM Kynam Global Healthcare Master 10% Owner Aug 10 '23 Buy 5.96 86,414 515,027 5,142,111 Aug 16 07:11 PM Kynam Capital Management, LP 10% Owner Aug 10 '23 Buy 5.96 86,414 515,027 5,142,111 Aug 14 08:51 PM Leschly Nick President and CEO Aug 03 '23 Sale 6.13 9,060 55,499 1,168,654 Aug 07 04:07 PM Baird William D III Chief Financial Officer Aug 03 '23 Sale 6.13 6,906 42,304 203,397 Aug 07 04:06 PM Gregory Philip D Chief Scientific Officer Aug 03 '23 Sale 6.13 3,966 24,295 263,409 Aug 07 04:06 PM
Index - P/E - EPS (ttm) -5.25 Insider Own 37.76% Shs Outstand 25.98M Perf Week 76.99%
Market Cap 546.85M Forward P/E - EPS next Y -0.68 Insider Trans -7.20% Shs Float 16.27M Perf Month 124.22%
Income -135.02M PEG - EPS next Q -0.48 Inst Own 42.38% Short Float 6.57% Perf Quarter 443.38%
Sales 221.85M P/S 2.46 EPS this Y 65.21% Inst Trans -11.90% Short Ratio 3.49 Perf Half Y 683.52%
Book/sh 7.93 P/B 2.64 EPS next Y 62.29% ROA -28.73% Short Interest 1.07M Perf Year 153.07%
Cash/sh 4.32 P/C 4.84 EPS next 5Y - ROE -50.41% 52W Range 1.16 - 18.24 Perf YTD 660.73%
Dividend Est. - P/FCF - EPS past 5Y - ROI -41.99% 52W High 14.69% Beta 2.26
Dividend TTM - Quick Ratio 2.99 Sales past 5Y 5.08% Gross Margin 38.95% 52W Low 1703.45% ATR (14) 1.70
Dividend Ex-Date - Current Ratio 3.22 EPS Y/Y TTM 88.17% Oper. Margin -53.62% RSI (14) 83.59 Volatility 16.26% 12.21%
Employees 1000 Debt/Eq 0.58 Sales Y/Y TTM -0.91% Profit Margin -60.86% Recom 2.00 Target Price 11.38
Option/Short Yes / Yes LT Debt/Eq 0.55 EPS Q/Q 74.45% Payout - Rel Volume 7.34 Prev Close 17.07
Sales Surprise 26.23% EPS Surprise 62.83% Sales Q/Q 44.70% Earnings Apr 29 AMC Avg Volume 305.98K Price 20.92
SMA20 94.99% SMA50 119.10% SMA200 304.31% Trades
Volume 2,246,377 Change 22.55%
Apr-30-24 07:31AM
Apr-29-24 08:55PM
05:50PM
04:05PM
Apr-23-24 08:30AM
04:05PM
Loading…
Apr-04-24 04:05PM
Mar-21-24 09:55AM
Mar-14-24 08:30AM
Feb-26-24 04:05PM
Feb-21-24 08:33AM
Feb-20-24 04:26PM
Feb-01-24 04:30PM
Jan-24-24 04:30PM
Jan-08-24 08:55AM
Dec-01-23 08:30AM
04:05PM
Loading…
Nov-28-23 04:05PM
Nov-20-23 04:05PM
Nov-10-23 09:55AM
Nov-05-23 12:10PM
Oct-31-23 08:19AM
(Thomson Reuters StreetEvents) -30.34%
Oct-30-23 06:02PM
04:05PM
Oct-09-23 04:05PM
Sep-22-23 04:05PM
Sep-13-23 01:01PM
Sep-11-23 08:00AM
Sep-06-23 08:00AM
Aug-21-23 07:00AM
Aug-09-23 08:16AM
07:59AM
(Thomson Reuters StreetEvents)
08:05PM
Loading…
Aug-08-23 08:05PM
04:05PM
Aug-07-23 08:00AM
Jul-19-23 07:05AM
Jul-18-23 04:05PM
Jun-28-23 07:00AM
Jun-26-23 04:01PM
Jun-20-23 07:00AM
May-24-23 04:05PM
May-23-23 07:00AM
May-22-23 04:05PM
May-15-23 09:35AM
May-09-23 04:05PM
May-04-23 07:00AM
May-03-23 01:06PM
Apr-28-23 06:39PM
08:10AM
07:04AM
Apr-18-23 04:05PM
12:55PM
Apr-03-23 08:30AM
Mar-22-23 04:36PM
Mar-20-23 09:07PM
08:45AM
Mar-18-23 06:48PM
Mar-16-23 08:45AM
Mar-14-23 04:16PM
Mar-01-23 07:30AM
Feb-28-23 08:30AM
Feb-21-23 04:30PM
Feb-16-23 08:30AM
Jan-31-23 04:15PM
Jan-30-23 08:30AM
Jan-27-23 06:00AM
Jan-26-23 04:53PM
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Feeley Kevin CHIEF FINANCIAL OFFICER Apr 29 '24 Option Exercise 0.00 3,013 0 31,940 Apr 30 04:27 PM Stueland Katherine Chief Executive Officer Apr 29 '24 Option Exercise 0.00 15,496 0 82,194 Apr 30 04:30 PM Stueland Katherine Chief Executive Officer Apr 29 '24 Sale 11.04 6,325 69,808 75,869 Apr 30 04:30 PM Feeley Kevin CHIEF FINANCIAL OFFICER Apr 29 '24 Sale 11.04 1,104 12,185 30,836 Apr 30 04:27 PM Stueland Katherine CHIEF EXECUTIVE OFFICER Mar 18 '24 Sale 10.59 8,559 90,661 66,698 Mar 19 04:15 PM Feeley Kevin CHIEF FINANCIAL OFFICER Mar 18 '24 Sale 10.59 3,253 34,455 28,927 Mar 19 04:14 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Mar 18 '24 Sale 10.59 2,008 21,269 29,517 Mar 19 04:14 PM Stueland Katherine CHIEF EXECUTIVE OFFICER Mar 16 '24 Option Exercise 0.00 18,750 0 75,257 Mar 19 04:15 PM Feeley Kevin CHIEF FINANCIAL OFFICER Mar 16 '24 Option Exercise 0.00 7,197 0 32,180 Mar 19 04:14 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Mar 16 '24 Option Exercise 0.00 5,114 0 31,525 Mar 19 04:14 PM Stueland Katherine CHIEF EXECUTIVE OFFICER Mar 12 '24 Sale 9.21 2,618 24,111 56,507 Mar 13 04:24 PM Feeley Kevin CHIEF FINANCIAL OFFICER Mar 12 '24 Sale 9.21 931 8,574 24,983 Mar 13 04:28 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Mar 12 '24 Sale 9.21 897 8,261 26,411 Mar 13 04:22 PM Feeley Kevin CHIEF FINANCIAL OFFICER Mar 09 '24 Option Exercise 0.00 2,462 0 25,914 Mar 12 05:27 PM Stueland Katherine CHIEF EXECUTIVE OFFICER Mar 09 '24 Option Exercise 0.00 6,547 0 59,125 Mar 12 05:26 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Mar 09 '24 Option Exercise 0.00 2,841 0 27,308 Mar 12 05:25 PM Casdin Capital, LLC Director Mar 05 '24 Buy 8.83 900 7,944 2,703,509 Mar 06 07:32 PM Casdin Capital, LLC Director Mar 04 '24 Buy 8.74 40,000 349,708 2,702,609 Mar 06 07:32 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Jan 22 '24 Sale 3.24 193 625 24,467 Jan 23 04:10 PM Saad Kareem CHIEF TRANSFORMATION OFFICER Jan 19 '24 Option Exercise 0.00 546 0 24,660 Jan 23 04:10 PM Saad Kareem Chief Transformation Officer Jan 03 '24 Sale 2.58 105 271 24,114 Jan 04 05:03 PM Saad Kareem Chief Transformation Officer Jan 01 '24 Option Exercise 0.00 273 0 24,219 Jan 03 04:25 PM Ryan Jason Executive Chairman Dec 31 '23 Option Exercise 0.00 67,780 0 73,614 Jan 03 04:23 PM Stueland Katherine Chief Executive Officer Dec 18 '23 Sale 2.16 11,734 25,338 52,578 Dec 19 09:26 PM Feeley Kevin Chief Financial Officer Dec 18 '23 Sale 2.16 2,948 6,366 23,035 Dec 19 09:24 PM Saad Kareem Chief Transformation Officer Dec 18 '23 Sale 2.16 1,700 3,671 23,946 Dec 19 09:25 PM Stueland Katherine Chief Executive Officer Dec 16 '23 Option Exercise 0.00 18,750 0 64,312 Dec 19 09:26 PM Feeley Kevin Chief Financial Officer Dec 16 '23 Option Exercise 0.00 7,197 0 25,983 Dec 19 09:24 PM Saad Kareem Chief Transformation Officer Dec 16 '23 Option Exercise 0.00 5,114 0 25,646 Dec 19 09:25 PM Stueland Katherine Chief Executive Officer Dec 11 '23 Sale 1.61 3,673 5,915 45,562 Dec 12 04:06 PM Feeley Kevin Chief Financial Officer Dec 11 '23 Sale 1.61 908 1,462 18,786 Dec 12 04:04 PM Saad Kareem Chief Transformation Officer Dec 11 '23 Sale 1.61 850 1,369 20,532 Dec 12 04:05 PM Saad Kareem Chief Transformation Officer Dec 09 '23 Option Exercise 0.00 2,841 0 21,382 Dec 12 04:05 PM Stueland Katherine Chief Executive Officer Dec 09 '23 Option Exercise 0.00 6,546 0 49,235 Dec 12 04:06 PM Feeley Kevin Chief Financial Officer Dec 09 '23 Option Exercise 0.00 2,462 0 19,694 Dec 12 04:04 PM Feeley Kevin Chief Financial Officer Dec 04 '23 Sale 1.77 270 478 17,232 Dec 05 04:45 PM Ryan Jason Executive Chairman Nov 17 '23 Buy 1.54 58,000 89,181 114,742 Nov 20 04:32 PM Ryan Jason Executive Chairman Nov 16 '23 Buy 1.27 56,742 72,187 56,742 Nov 20 04:32 PM Meister Keith A. Director Nov 15 '23 Sale 1.29 883,742 1,140,027 3,011,066 Nov 17 04:18 PM PFENNIGER RICHARD C JR Director Nov 08 '23 Buy 1.49 10,000 14,889 20,918 Nov 08 07:19 PM Saad Kareem Chief Transformation Officer Oct 20 '23 Sale 3.44 164 564 18,541 Oct 23 05:52 PM Ryan Jason Executive Chairman Oct 17 '23 Sale 3.19 42 134 5,834 Oct 18 04:59 PM Saad Kareem Chief Transformation Officer Oct 03 '23 Sale 3.56 85 303 18,159 Oct 03 04:19 PM Stueland Katherine Chief Executive Officer Sep 18 '23 Sale 4.16 10,752 44,749 42,689 Sep 19 06:09 PM Feeley Kevin Chief Financial Officer Sep 18 '23 Sale 4.16 2,742 11,409 16,785 Sep 19 06:08 PM Saad Kareem Chief Transformation Officer Sep 18 '23 Sale 4.16 1,580 6,575 17,971 Sep 19 06:08 PM Feeley Kevin Chief Financial Officer Sep 16 '23 Option Exercise 0.00 7,197 0 19,527 Sep 19 06:08 PM Stueland Katherine Chief Executive Officer Sep 11 '23 Sale 4.62 2,675 12,369 34,691 Sep 12 06:42 PM Feeley Kevin Chief Financial Officer Sep 11 '23 Sale 4.62 904 4,180 12,330 Sep 12 06:40 PM Saad Kareem Chief Transformation Officer Sep 11 '23 Sale 4.62 846 3,912 14,437 Sep 12 06:41 PM Feeley Kevin Chief Financial Officer Sep 09 '23 Option Exercise 0.00 2,462 0 13,234 Sep 12 06:40 PM Feeley Kevin Chief Financial Officer Sep 05 '23 Sale 4.38 269 1,178 10,772 Sep 06 04:56 PM PFENNIGER RICHARD C JR Director Aug 17 '23 Buy 5.10 5,000 25,523 10,918 Aug 18 05:10 PM White Karen Ann Chief People Officer Jul 26 '23 Sale 7.41 61 452 4,761 Jul 27 04:12 PM Saad Kareem Chief Transformation Officer Jul 20 '23 Sale 7.85 163 1,280 12,442 Jul 21 09:58 PM Saad Kareem Chief Transformation Officer Jul 03 '23 Sale 5.99 83 497 12,059 Jul 05 05:16 PM White Karen Ann Chief People Officer Jul 03 '23 Sale 5.99 45 270 4,685 Jul 05 05:18 PM Stueland Katherine Chief Executive Officer Jun 20 '23 Sale 6.37 7,965 50,727 30,819 Jun 21 04:05 PM Feeley Kevin Chief Financial Officer Jun 20 '23 Sale 6.37 2,744 17,473 10,324 Jun 21 04:06 PM White Karen Ann Chief People Officer Jun 20 '23 Sale 6.37 1,549 9,865 4,631 Jun 21 04:05 PM Saad Kareem Chief Transformation Officer Jun 20 '23 Sale 6.37 1,221 7,774 11,869 Jun 21 04:04 PM Feeley Kevin Chief Financial Officer Jun 16 '23 Option Exercise 0.00 7,197 0 13,068 Jun 21 04:06 PM Feeley Kevin Chief Financial Officer Jun 13 '23 Sale 6.49 903 5,860 5,871 Jun 13 05:19 PM Stueland Katherine Chief Executive Officer Jun 12 '23 Sale 6.49 2,674 17,354 20,034 Jun 13 05:23 PM Saad Kareem Chief Transformation Officer Jun 12 '23 Sale 6.49 845 5,484 7,976 Jun 13 05:22 PM White Karen Ann Chief People Officer Jun 12 '23 Sale 6.49 828 5,374 2,770 Jun 13 05:25 PM Feeley Kevin Chief Financial Officer Jun 09 '23 Option Exercise 0.00 2,462 0 6,774 Jun 13 05:19 PM Feeley Kevin Chief Financial Officer Jun 02 '23 Sale 7.00 263 1,841 4,312 Jun 05 04:42 PM PFENNIGER RICHARD C JR Director May 18 '23 Buy 5.90 5,000 29,500 5,918 May 22 04:59 PM Stueland Katherine Chief Executive Officer May 16 '23 Sale 6.50 8,685 56,439 16,162 May 18 07:21 PM Feeley Kevin Chief Financial Officer May 16 '23 Sale 6.50 1,516 9,852 3,856 May 18 07:22 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
